The east coast is recovering this Monday after a brutally cold weekend following the bomb cyclone. Sara Miller, Editor at Live Science, joins Cheddar to discuss what we can expect for the rest of the winter and what signs we should look out for when it comes to global warming.
New England bore the brunt of the snow. Miller says the wind chill on Mount Washington in New Hampshire hit negative 90 degrees! Miller did deliver some good news for us here in New York...the temperature is supposed to climb into the 60s this week.
Some believe this has to do with global warming. However, Miller warns we can't just look at this one storm as a sign of global warming. She says that around the globe, temperatures are actually warmer than usual. One example is Australia. The country just hit a record for the hottest day at 117 degrees.
The Food and Drug Administration is changing its policy to make it easier for gay men to donate blood.
Blue Origin is sending an all-female crew into orbit next year, according to The Wall Street Journal.
Jeff Bezos' girlfriend is leading an all-female space mission aboard a Blue Origin spacecraft.
The Food and Drug Administration is raising concerns about the long-term effects of CBD.
CVS and Walmart are cutting back pharmacy hours due to a shortage of pharmacists.
The U.S. plans to make it easier for gay and bisexual men to give blood by easing restrictions on groups that typically face higher risks of HIV.
Five former Memphis police officers were charged with murder in the death of Tyre Nichols, the FDA explores yearly COVID vaccines, and New York City explores electric Uber and Lyft rides. Here is everything you Need2Know for Friday, January 27, 2023.
The Food and Drug Administration is joining an international probe that is taking a closer look at some cough syrups that have killed over 300 children worldwide.
Payam Banazadeh, founder and CEO of Capella Space, joined Cheddar News to discuss the satellite imagery company's latest $60 million funding and what government projects lie ahead.
Ants could be the next line of defense against cancer, according to a study.
